<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC7564522/table_3" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 3</label>
  <p>Alternative assumptions used for the risk of death experienced by those PLHIV whose ART supply is interrupted.</p>
 </caption>
 <thead>
  <tr>
   <th valign="top" colspan="1" rowspan="1" id="0-0-."/>
   <th valign="top" colspan="1" rowspan="1" id="0-1-.">
    <i>Average monthly mortality risk</i>
   </th>
   <th valign="top" colspan="1" rowspan="1" id="0-2-.">
    <i>Proportion that would die after one year</i>
   </th>
   <th valign="top" colspan="1" rowspan="1" id="0-3-.">
    <i>Justification</i>
   </th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td valign="top">
    <i>Lower bound</i>
   </td>
   <td valign="top">0.10%</td>
   <td valign="top">1.24%</td>
   <td valign="top">This is a hypothetical best-case scenario in which the vast majority of individuals do not deteriorate rapidly.</td>
  </tr>
  <tr>
   <td valign="top">
    <i>Medium</i>
   </td>
   <td valign="top">0.24%</td>
   <td valign="top">2.91%</td>
   <td valign="top">The SMART trial found a 3% risk at 12 months of either death of an opportunistic infection for those with interrupted ART 
    <a rid="bib0013" ref-type="bibr">[13]</a>. This also implies a mean survival time approximately equivalent to that for HIV-positive persons who have never been on ART 
    <a rid="bib0014" ref-type="bibr">[14]</a>. 
   </td>
  </tr>
  <tr>
   <td valign="top">
    <i>Upper bound</i>
   </td>
   <td valign="top">0.44%</td>
   <td valign="top">5.28%</td>
   <td valign="top">This is the hypothetical worst-case scenario in which many persons deteriorate more rapidly.</td>
  </tr>
 </tbody>
</table>
